Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hsu

Showing results (1131-1140 of 1,368) with videos related to

Pageof 137
Sort By:
American Journal of Translational Research|January 29, 2015
Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cellsLongfei Huo, Chia-Wei Li, Tzu-Hsuan Huang, et al.
Transplantation and Cellular Therapy|August 16, 2025
Bronchiectasis in Bronchiolitis Obliterans Syndrome after Hematopoietic Cell TransplantationDavid J Epstein, Nidia Rodriguez-Ormaza, Husham Sharifi, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
American Journal of Cancer Research|April 13, 2017
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinomaChun-Te Chen, Yi-Chun Chen, Yi Du, et al.
Mucosal Immunology|January 25, 2018
Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitisJ B Wechsler, A Szabo, C L Hsu, et al.
The Journal of Clinical Investigation|April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumabFrancesco Cortiula, Talia Shentzer Kutiel, Melinda L Hsu, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
BMC Health Services Research|March 6, 2024
Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registryGustavo G Mendez, Judith M Nocek, Donald J Brambilla, et al.
Nature Communications|January 28, 2021
Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamicsMonica C Pillon, Meredith N Frazier, Lucas B Dillard, et al.
Pageof 137

Showing results (1131-1140 of 1,368) with videos related to

Sort By:
Pageof 137
American Journal of Translational Research|January 29, 2015
Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cellsLongfei Huo, Chia-Wei Li, Tzu-Hsuan Huang, et al.
Transplantation and Cellular Therapy|August 16, 2025
Bronchiectasis in Bronchiolitis Obliterans Syndrome after Hematopoietic Cell TransplantationDavid J Epstein, Nidia Rodriguez-Ormaza, Husham Sharifi, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
American Journal of Cancer Research|April 13, 2017
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinomaChun-Te Chen, Yi-Chun Chen, Yi Du, et al.
Mucosal Immunology|January 25, 2018
Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitisJ B Wechsler, A Szabo, C L Hsu, et al.
The Journal of Clinical Investigation|April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumabFrancesco Cortiula, Talia Shentzer Kutiel, Melinda L Hsu, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
BMC Health Services Research|March 6, 2024
Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registryGustavo G Mendez, Judith M Nocek, Donald J Brambilla, et al.
Nature Communications|January 28, 2021
Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamicsMonica C Pillon, Meredith N Frazier, Lucas B Dillard, et al.
Pageof 137